本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

44.43
-0.3100-0.69%
盘后44.820.3886+0.87%19:46 EDT
成交量:80.34万
成交额:3,574.34万
市值:41.32亿
市盈率:-192.87
高:45.00
开:44.39
低:44.12
收:44.74
52周最高:48.61
52周最低:13.88
股本:9,299.29万
流通股本:9,122.00万
量比:0.53
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-0.2304
每股收益(LYR):-0.2864
净资产收益率:-69.38%
总资产收益率:-6.46%
市净率:41.85
市盈率(LYR):-155.16

数据加载中...

2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities